Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 10—October 2010

Research

Effectiveness of Personal Protective Equipment and Oseltamivir Prophylaxis during Avian Influenza A (H7N7) Epidemic, the Netherlands, 2003

Dennis E. te BeestComments to Author , Michiel van Boven, Marian E.H. Bos, Arjan Stegeman, and Marion P.G. Koopmans
Author affiliations: Author affiliations: Utrecht University, Utrecht, the Netherlands (D.E. te Beest, M.E.H. Bos, A. Stegeman); National Institute of Public Health and the Environment, Bilthoven, the Netherlands (D.E. te Beest, M. van Boven, M.P.G. Koopmans)

Main Article

Table 1

Number of infections and use of oseltamivir prophylaxis during avian influenza A (H7N7) epidemic, on the basis of combined conjunctivitis and serology-based case definition, the Netherlands, 2003*

Oseltamivir use No. persons
 No. visits
Infected Total By infected persons Total†
Not prescribed 4 16 6 26
Prescribed but not used during visit 9 34 17 64
Prescribed and used consistently 4 41 6 85
Prescribed and used inconsistently 2 18 7 39
Prescribed and consistency of use unknown 2 7 2 18
Prescribed but period of use unknown 2 29 5 64

*Data resulted from a survey conducted among poultry workers after the epidemic.
†Because visits were classified into groups, persons may be in 2 categories (prescribed/not used and prescribed/used).

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO